Healio
Healio

Sitemap

May 30, 2009 Articles

Filter by Available Specialty

Filter by specialty

  1. 5-FU, mitomycin-C confirmed as standard of care in anal cancer
  2. ATLAS: Adding erlotinib to bevacizumab for maintenance therapy improved PFS in NSCLC
  3. NSABP C-08: Bevacizumab plus standard therapy failed to improve DFS in early-stage colon cancer
  4. SYMMETRY halted early; elesclomol/paclitaxel fails to increase PFS for metastatic melanoma